LUNG250117C10000
- 0.00
- 0.000.00%
Pulmonx Newsroom
Wells Fargo Maintains Pulmonx(LUNG.US) With Hold Rating, Maintains Target Price $8
Citi Maintains Pulmonx(LUNG.US) With Hold Rating
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Pulmonx Is Maintained at Equal-Weight by Wells Fargo
Pulmonx Cut to Neutral From Buy by Citigroup
Pulmonx Price Target Cut to $7.50/Share From $17.00 by Citigroup
Pulmonx Analyst Ratings
Wells Fargo Maintains Pulmonx(LUNG.US) With Hold Rating, Announces Target Price $8
Citi Downgrades Pulmonx(LUNG.US) to Hold Rating, Cuts Target Price to $7.5
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Pulmonx Analyst Ratings
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Cuts Target Price to $16
CCORF Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Piper Sandler Maintains Pulmonx(LUNG.US) With Buy Rating, Cuts Target Price to $10
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $17
Analysts Are Bullish on Top Healthcare Stocks: Pulmonx (LUNG), Omnicell (OMCL)